Abraxis Bioscience Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 501

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $3B

Abraxis Bioscience General Information

Description

Provider of bio-medical services for cancer and other critical illnesses. The company is engaged in the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients different types of treatments. It offers a nanoparticle chemotherapeutic compound that is based on its proprietary tumor targeting nab technology platform for the treatment of metastatic breast cancer.

Contact Information

Website
www.abraxisbio.com
Formerly Known As
Abraxis Biosciences, Inc., New Abraxis, Inc.
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11755 Wilshire Boulevard
  • Suite 2000
  • Los Angeles, CA 90025
  • United States
Primary Industry
Biotechnology
Acquirer
Celgene
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 11755 Wilshire Boulevard
  • Suite 2000
  • Los Angeles, CA 90025
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abraxis Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 15-Oct-2010 $3B Completed Generating Revenue
2. IPO 14-Nov-2007 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Abraxis Bioscience’s complete valuation and funding history, request access »

Abraxis Bioscience Patents

  • 32

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • Pending

  • Expiring in next 12 mo

Abraxis Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100302222-A1 Lcd and display property adjusting method thereof Active 31-May-2009
US-8243054-B2 Lcd and display property adjusting method thereof Inactive 31-May-2009
US-20090264443-A1 Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds Inactive 18-Apr-2008
US-20110172242-A1 Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds Inactive 18-Apr-2008
US-20090156609-A1 Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperzaine compounds Inactive 09-Nov-2007 A61K31/497
To view Abraxis Bioscience’s complete patent history, request access »

Abraxis Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abraxis Bioscience Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fresenius Kabi USA Corporation Minority
Vivo Capital Venture Capital Minority
To view Abraxis Bioscience’s complete investors history, request access »

Abraxis Bioscience Investments & Acquisitions (3)

Abraxis Bioscience’s most recent deal was a Corporate with Ideal Life. The deal was made on 01-Oct-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ideal Life 01-Oct-2010 Corporate Other Healthcare Technology Systems
Stalar 4 09-Dec-2009 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
Pfizer (Cruce Dávila Manufacturing Facility) 14-Feb-2007 Corporate Asset Purchase Buildings and Property
To view Abraxis Bioscience’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Abraxis Bioscience FAQs

  • When was Abraxis Bioscience founded?

    Abraxis Bioscience was founded in 2001.

  • Where is Abraxis Bioscience headquartered?

    Abraxis Bioscience is headquartered in Los Angeles, CA.

  • What is the size of Abraxis Bioscience?

    Abraxis Bioscience has 501 total employees.

  • What industry is Abraxis Bioscience in?

    Abraxis Bioscience’s primary industry is Biotechnology.

  • Is Abraxis Bioscience a private or public company?

    Abraxis Bioscience is a Private company.

  • What is the current valuation of Abraxis Bioscience?

    The current valuation of Abraxis Bioscience is .

  • What is Abraxis Bioscience’s current revenue?

    The current revenue for Abraxis Bioscience is .

  • Who are Abraxis Bioscience’s investors?

    Fresenius Kabi USA and Vivo Capital have invested in Abraxis Bioscience.

  • When was Abraxis Bioscience acquired?

    Abraxis Bioscience was acquired on 15-Oct-2010.

  • Who acquired Abraxis Bioscience?

    Abraxis Bioscience was acquired by Celgene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process